Ticking Off Investors, Akari CEO Exits Amid Coversin Trial Controversy

 
• By Sten Stovall
  
Tick
Message From Investors To Akari: Don't Bite The Hand That Feeds You !! • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D